0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Type 1 Diabetes Market Insights, Forecast to 2028
Published Date: April 2022
|
Report Code: QYRE-Auto-32X2217
Home | Market Reports | Health | Health Conditions | Endocrine Conditions
Global Type 1 Diabetes Market Insights Forecast to 2028

Global Type 1 Diabetes Market Insights, Forecast to 2028

Code: QYRE-Auto-32X2217
Report
April 2022
108 Pages
QYResearch
Region: Global, North America, Japan, Europe, Central & South America,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Type 1 Diabetes Market

The global Type 1 Diabetes market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Rapid Acting Insulin Analogs accounting for % of the Type 1 Diabetes global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Type 1 Diabetes market size is valued at US$ million in 2021, while the North America and Europe Type 1 Diabetes are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Type 1 Diabetes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Type 1 Diabetes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Type 1 Diabetes market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Type 1 Diabetes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Type 1 Diabetes market.
Global Type 1 Diabetes Scope and Market Size
Type 1 Diabetes market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Type 1 Diabetes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs

Segment by Application

Hospitals
Diagnostic clinics

BY COMPANY

Abbott
Bayer
Eli Lilly
BD
Johnson & Johnson
Merck
Pfizer
AstraZeneca
Roche
Smiths Medical
Medtronic

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type 1 Diabetes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Rapid Acting Insulin Analogs
1.2.3 Long Acting Insulin Analogs
1.2.4 Premix Insulin Analogs
1.3 Market by Application
1.3.1 Global Type 1 Diabetes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Type 1 Diabetes Market Perspective (2017-2028)
2.2 Type 1 Diabetes Growth Trends by Region
2.2.1 Type 1 Diabetes Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Type 1 Diabetes Historic Market Size by Region (2017-2022)
2.2.3 Type 1 Diabetes Forecasted Market Size by Region (2023-2028)
2.3 Type 1 Diabetes Market Dynamics
2.3.1 Type 1 Diabetes Industry Trends
2.3.2 Type 1 Diabetes Market Drivers
2.3.3 Type 1 Diabetes Market Challenges
2.3.4 Type 1 Diabetes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Type 1 Diabetes Players by Revenue
3.1.1 Global Top Type 1 Diabetes Players by Revenue (2017-2022)
3.1.2 Global Type 1 Diabetes Revenue Market Share by Players (2017-2022)
3.2 Global Type 1 Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Type 1 Diabetes Revenue
3.4 Global Type 1 Diabetes Market Concentration Ratio
3.4.1 Global Type 1 Diabetes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type 1 Diabetes Revenue in 2021
3.5 Type 1 Diabetes Key Players Head office and Area Served
3.6 Key Players Type 1 Diabetes Product Solution and Service
3.7 Date of Enter into Type 1 Diabetes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Type 1 Diabetes Breakdown Data by Type
4.1 Global Type 1 Diabetes Historic Market Size by Type (2017-2022)
4.2 Global Type 1 Diabetes Forecasted Market Size by Type (2023-2028)
5 Type 1 Diabetes Breakdown Data by Application
5.1 Global Type 1 Diabetes Historic Market Size by Application (2017-2022)
5.2 Global Type 1 Diabetes Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Type 1 Diabetes Market Size (2017-2028)
6.2 North America Type 1 Diabetes Market Size by Type
6.2.1 North America Type 1 Diabetes Market Size by Type (2017-2022)
6.2.2 North America Type 1 Diabetes Market Size by Type (2023-2028)
6.2.3 North America Type 1 Diabetes Market Share by Type (2017-2028)
6.3 North America Type 1 Diabetes Market Size by Application
6.3.1 North America Type 1 Diabetes Market Size by Application (2017-2022)
6.3.2 North America Type 1 Diabetes Market Size by Application (2023-2028)
6.3.3 North America Type 1 Diabetes Market Share by Application (2017-2028)
6.4 North America Type 1 Diabetes Market Size by Country
6.4.1 North America Type 1 Diabetes Market Size by Country (2017-2022)
6.4.2 North America Type 1 Diabetes Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Type 1 Diabetes Market Size (2017-2028)
7.2 Europe Type 1 Diabetes Market Size by Type
7.2.1 Europe Type 1 Diabetes Market Size by Type (2017-2022)
7.2.2 Europe Type 1 Diabetes Market Size by Type (2023-2028)
7.2.3 Europe Type 1 Diabetes Market Share by Type (2017-2028)
7.3 Europe Type 1 Diabetes Market Size by Application
7.3.1 Europe Type 1 Diabetes Market Size by Application (2017-2022)
7.3.2 Europe Type 1 Diabetes Market Size by Application (2023-2028)
7.3.3 Europe Type 1 Diabetes Market Share by Application (2017-2028)
7.4 Europe Type 1 Diabetes Market Size by Country
7.4.1 Europe Type 1 Diabetes Market Size by Country (2017-2022)
7.4.2 Europe Type 1 Diabetes Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Type 1 Diabetes Market Size (2017-2028)
8.2 Asia-Pacific Type 1 Diabetes Market Size by Type
8.2.1 Asia-Pacific Type 1 Diabetes Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Type 1 Diabetes Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Type 1 Diabetes Market Share by Type (2017-2028)
8.3 Asia-Pacific Type 1 Diabetes Market Size by Application
8.3.1 Asia-Pacific Type 1 Diabetes Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Type 1 Diabetes Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Type 1 Diabetes Market Share by Application (2017-2028)
8.4 Asia-Pacific Type 1 Diabetes Market Size by Region
8.4.1 Asia-Pacific Type 1 Diabetes Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Type 1 Diabetes Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Type 1 Diabetes Market Size (2017-2028)
9.2 Latin America Type 1 Diabetes Market Size by Type
9.2.1 Latin America Type 1 Diabetes Market Size by Type (2017-2022)
9.2.2 Latin America Type 1 Diabetes Market Size by Type (2023-2028)
9.2.3 Latin America Type 1 Diabetes Market Share by Type (2017-2028)
9.3 Latin America Type 1 Diabetes Market Size by Application
9.3.1 Latin America Type 1 Diabetes Market Size by Application (2017-2022)
9.3.2 Latin America Type 1 Diabetes Market Size by Application (2023-2028)
9.3.3 Latin America Type 1 Diabetes Market Share by Application (2017-2028)
9.4 Latin America Type 1 Diabetes Market Size by Country
9.4.1 Latin America Type 1 Diabetes Market Size by Country (2017-2022)
9.4.2 Latin America Type 1 Diabetes Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Type 1 Diabetes Market Size (2017-2028)
10.2 Middle East & Africa Type 1 Diabetes Market Size by Type
10.2.1 Middle East & Africa Type 1 Diabetes Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Type 1 Diabetes Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Type 1 Diabetes Market Share by Type (2017-2028)
10.3 Middle East & Africa Type 1 Diabetes Market Size by Application
10.3.1 Middle East & Africa Type 1 Diabetes Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Type 1 Diabetes Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Type 1 Diabetes Market Share by Application (2017-2028)
10.4 Middle East & Africa Type 1 Diabetes Market Size by Country
10.4.1 Middle East & Africa Type 1 Diabetes Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Type 1 Diabetes Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Type 1 Diabetes Introduction
11.1.4 Abbott Revenue in Type 1 Diabetes Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Type 1 Diabetes Introduction
11.2.4 Bayer Revenue in Type 1 Diabetes Business (2017-2022)
11.2.5 Bayer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Type 1 Diabetes Introduction
11.3.4 Eli Lilly Revenue in Type 1 Diabetes Business (2017-2022)
11.3.5 Eli Lilly Recent Developments
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Type 1 Diabetes Introduction
11.4.4 BD Revenue in Type 1 Diabetes Business (2017-2022)
11.4.5 BD Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Type 1 Diabetes Introduction
11.5.4 Johnson & Johnson Revenue in Type 1 Diabetes Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Type 1 Diabetes Introduction
11.6.4 Merck Revenue in Type 1 Diabetes Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Type 1 Diabetes Introduction
11.7.4 Pfizer Revenue in Type 1 Diabetes Business (2017-2022)
11.7.5 Pfizer Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Type 1 Diabetes Introduction
11.8.4 AstraZeneca Revenue in Type 1 Diabetes Business (2017-2022)
11.8.5 AstraZeneca Recent Developments
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Type 1 Diabetes Introduction
11.9.4 Roche Revenue in Type 1 Diabetes Business (2017-2022)
11.9.5 Roche Recent Developments
11.10 Smiths Medical
11.10.1 Smiths Medical Company Details
11.10.2 Smiths Medical Business Overview
11.10.3 Smiths Medical Type 1 Diabetes Introduction
11.10.4 Smiths Medical Revenue in Type 1 Diabetes Business (2017-2022)
11.10.5 Smiths Medical Recent Developments
11.11 Medtronic
11.11.1 Medtronic Company Details
11.11.2 Medtronic Business Overview
11.11.3 Medtronic Type 1 Diabetes Introduction
11.11.4 Medtronic Revenue in Type 1 Diabetes Business (2017-2022)
11.11.5 Medtronic Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Type 1 Diabetes Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Rapid Acting Insulin Analogs
    Table 3. Key Players of Long Acting Insulin Analogs
    Table 4. Key Players of Premix Insulin Analogs
    Table 5. Global Type 1 Diabetes Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Type 1 Diabetes Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Type 1 Diabetes Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Type 1 Diabetes Market Share by Region (2017-2022)
    Table 9. Global Type 1 Diabetes Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Type 1 Diabetes Market Share by Region (2023-2028)
    Table 11. Type 1 Diabetes Market Trends
    Table 12. Type 1 Diabetes Market Drivers
    Table 13. Type 1 Diabetes Market Challenges
    Table 14. Type 1 Diabetes Market Restraints
    Table 15. Global Type 1 Diabetes Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Type 1 Diabetes Revenue Share by Players (2017-2022)
    Table 17. Global Top Type 1 Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes as of 2021)
    Table 18. Ranking of Global Top Type 1 Diabetes Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Type 1 Diabetes Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Type 1 Diabetes Product Solution and Service
    Table 22. Date of Enter into Type 1 Diabetes Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Type 1 Diabetes Revenue Market Share by Type (2017-2022)
    Table 26. Global Type 1 Diabetes Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Type 1 Diabetes Revenue Market Share by Type (2023-2028)
    Table 28. Global Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Type 1 Diabetes Revenue Share by Application (2017-2022)
    Table 30. Global Type 1 Diabetes Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Type 1 Diabetes Revenue Share by Application (2023-2028)
    Table 32. North America Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Type 1 Diabetes Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Type 1 Diabetes Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Abbott Company Details
    Table 63. Abbott Business Overview
    Table 64. Abbott Type 1 Diabetes Product
    Table 65. Abbott Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 66. Abbott Recent Developments
    Table 67. Bayer Company Details
    Table 68. Bayer Business Overview
    Table 69. Bayer Type 1 Diabetes Product
    Table 70. Bayer Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 71. Bayer Recent Developments
    Table 72. Eli Lilly Company Details
    Table 73. Eli Lilly Business Overview
    Table 74. Eli Lilly Type 1 Diabetes Product
    Table 75. Eli Lilly Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 76. Eli Lilly Recent Developments
    Table 77. BD Company Details
    Table 78. BD Business Overview
    Table 79. BD Type 1 Diabetes Product
    Table 80. BD Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 81. BD Recent Developments
    Table 82. Johnson & Johnson Company Details
    Table 83. Johnson & Johnson Business Overview
    Table 84. Johnson & Johnson Type 1 Diabetes Product
    Table 85. Johnson & Johnson Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 86. Johnson & Johnson Recent Developments
    Table 87. Merck Company Details
    Table 88. Merck Business Overview
    Table 89. Merck Type 1 Diabetes Product
    Table 90. Merck Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 91. Merck Recent Developments
    Table 92. Pfizer Company Details
    Table 93. Pfizer Business Overview
    Table 94. Pfizer Type 1 Diabetes Product
    Table 95. Pfizer Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 96. Pfizer Recent Developments
    Table 97. AstraZeneca Company Details
    Table 98. AstraZeneca Business Overview
    Table 99. AstraZeneca Type 1 Diabetes Product
    Table 100. AstraZeneca Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 101. AstraZeneca Recent Developments
    Table 102. Roche Company Details
    Table 103. Roche Business Overview
    Table 104. Roche Type 1 Diabetes Product
    Table 105. Roche Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 106. Roche Recent Developments
    Table 107. Smiths Medical Company Details
    Table 108. Smiths Medical Business Overview
    Table 109. Smiths Medical Type 1 Diabetes Product
    Table 110. Smiths Medical Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 111. Smiths Medical Recent Developments
    Table 112. Medtronic Company Details
    Table 113. Medtronic Business Overview
    Table 114. Medtronic Type 1 Diabetes Product
    Table 115. Medtronic Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 116. Medtronic Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Type 1 Diabetes Market Share by Type: 2021 VS 2028
    Figure 2. Rapid Acting Insulin Analogs Features
    Figure 3. Long Acting Insulin Analogs Features
    Figure 4. Premix Insulin Analogs Features
    Figure 5. Global Type 1 Diabetes Market Share by Application: 2021 VS 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Diagnostic clinics Case Studies
    Figure 8. Type 1 Diabetes Report Years Considered
    Figure 9. Global Type 1 Diabetes Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Type 1 Diabetes Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Type 1 Diabetes Market Share by Region: 2021 VS 2028
    Figure 12. Global Type 1 Diabetes Market Share by Players in 2021
    Figure 13. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Type 1 Diabetes Revenue in 2021
    Figure 15. North America Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Type 1 Diabetes Market Size Market Share by Type (2017-2028)
    Figure 17. North America Type 1 Diabetes Market Size Market Share by Application (2017-2028)
    Figure 18. North America Type 1 Diabetes Market Size Share by Country (2017-2028)
    Figure 19. United States Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Type 1 Diabetes Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Type 1 Diabetes Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Type 1 Diabetes Market Size Share by Country (2017-2028)
    Figure 25. Germany Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Type 1 Diabetes Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Type 1 Diabetes Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Type 1 Diabetes Market Size Share by Region (2017-2028)
    Figure 35. China Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Type 1 Diabetes Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Type 1 Diabetes Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Type 1 Diabetes Market Size Share by Country (2017-2028)
    Figure 45. Mexico Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Type 1 Diabetes Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Type 1 Diabetes Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Type 1 Diabetes Market Size Share by Country (2017-2028)
    Figure 51. Turkey Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Abbott Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 55. Bayer Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 56. Eli Lilly Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 57. BD Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 58. Johnson & Johnson Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 60. Pfizer Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 61. AstraZeneca Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 62. Roche Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 63. Smiths Medical Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 64. Medtronic Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global and United States Insulin Drug Delivery Devices Market Report Forecast 2022 2028
Global and United States Insulin Drug Delivery Devices Market Report & Forecast 2022-2028

Insulin delivery devices that are currently available for the administration of insulin include syringes insulin infusion pumps jet injectors and pens.Market Analysis and Insights Global and United States Insulin Drug Delivery Devices MarketThis report focuses on global and United States Insulin Drug Delivery Devices market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Insulin Drug Delivery Devices market size is estimated to be worth US 14710 million in 2022 and is forecast to a readjusted size of US 19310 million by 2028 with a CAGR of 4.6 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-37X10341
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global Diabetes Software Market Insights Forecast to 2028
Global Diabetes Software Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-9F2714
Fri Apr 08 00:00:00 UTC 2022

Add to Cart

United States Dipeptidyl Peptidase IV DPP IV Inhibitors Market Report Forecast 2021 2027
Global and United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-5X8306
Fri Apr 08 00:00:00 UTC 2022

Add to Cart

United States Disposable Insulin Pumps Market Report Forecast 2021 2027
Global and United States Disposable Insulin Pumps Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-33T8000
Fri Apr 08 00:00:00 UTC 2022

Add to Cart